Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience.
Saved in:
| Title: | Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. |
|---|---|
| Authors: | Sandeep, K. S.1,2 (AUTHOR) sandeepksrt15@gmail.com, Appachu, Sandhya3 (AUTHOR), Diwaker, Ravi B.3 (AUTHOR), Vivek, Sai3 (AUTHOR), Simha, Vijai V. S.3 (AUTHOR) |
| Source: | Indian Journal of Cancer. Oct-Dec2025, Vol. 62 Issue 4, p541-547. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0019509X |
|---|---|
| DOI: | 10.4103/ijc.ijc_643_23 |
